Clinical trial
The Efficacy, With Regard to Pain Relief, of Targinact® Treatment for Patients With Severe Pain Compared to Previous Analgesic Treatment; a Non-interventional Study.
NCT01983137 is registered in ClinicalTrials.gov with Mundipharma CVA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy, With Regard to Pain Relief, of Targinact® Treatment for Patients With Severe Pain Compared to Previous Analgesic Treatment; a Non-interventional Study.
- Lead sponsor
- Mundipharma CVA
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- December 31, 2012
- Enrollment
- 1,338 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe pain